Because of APOE4’s well-established prevalence in AD, its impact toward other CNS diseases has been investigated, including Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Traumatic Brain Injury (TBI), and PD (Fernández-Calle et al., 2022). Here, APOE is linked to Parkinson disease.